T. Rowe Price Associates »

Acumen Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.5M 1.0M 2.42
2024-03-31 $4.4M 1.1M 4.05

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Elevance Health Comm Stk (ELV)
Schwab Charles Corp Comm Stk (SCHW)

View all positions for T. Rowe Price Associates

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Franklin Resources
Rock Springs Capital Management
BlackRock
Millennium Management
Vanguard Group
Laurion Capital Management
T. Rowe Price Associates
Alyeska Investment Group
Geode Capital Management
Hudson Bay Capital Management
Pathstone Holdings
State Street Corporation
Jane Street
Two Sigma Advisers

View all funds holding Acumen Pharmaceuticals